Last $14.60 USD
Change Today +0.16 / 1.11%
Volume 161.2K
FLML On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William D. Dearstyne

Former Director, Flamel Technologies SA
AgeTotal Calculated CompensationThis person is connected to 29 board members in 2 different organizations across 3 different industries.

See Board Relationships
74--

Background*

Mr. William D. Dearstyne served as Non-Executive Vice-Chairman at Sonova Holding AG from 2004 to June 2011 and it's Non-Executive Director from 2003 to June 2011. Mr. Dearstyne has been a Director at Flamel Technologies S.A. since 2003. He serves as a Member of Advisory Board at Earlybird Venture Capital GmbH & Co. KG. Mr. Dearstyne was a Member of the Medical Devices and Diagnostics Group Operating Committee and Company Group Chairman for all Johnson & Johnson Professional ...

Read Full Background

Corporate Headquarters*

Parc Club du Moulin à Vent
Vénissieux, Rhône-Alpes 69693

France

Phone: 33 472 78 34 34
Fax: 33 472 78 34 35

Board Members Memberships*

Director
2003-N/A
Former Director
2003-2012
Former Non-Executive Vice-Chairman, Lead Director, Chairman of Nomination & Compensation Committee and Member of Audit Committee

Education*

Unknown/Other Education
Bucknell University
MBA
Syracuse University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FLML:US $14.60 USD +0.16

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
Ronald W. Barrett Ph.D.Co-Founder, Chief Executive Officer and Director
Xenoport, Inc.
$500.0K
Judith Greciet Ph.D., PharmacyChief Executive Officer, Director and Member of Corporate Development Committee
Onxeo SA
€276.9K
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
$739.3K
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FLAMEL TECHNOLOGIES-SP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.